| Date | Title | Description | Source |
| 22.03.2023 | PhoreMost Enhances Drug Discovery Process with CDD Vault | CDD Vault Integrates with SnapGene Server for Web-Based Sharing of Plasmid Information
BURLINGAME, ... | einpresswi... |
| 02.03.2022 | PhoreMost promotes Dr Neil Torbett to Chief Executive Office... | PhoreMost promotes Dr Neil Torbett to Chief Executive Officer
02-03-2022
PhoreMost Ltd., the UK-ba... | cambridgen... |
| 18.01.2022 | PhoreMost expands into new facility at Unity Campus, Cambrid... | PhoreMost expands into new facility at Unity Campus, Cambridge
18-01-2022
PhoreMost Ltd., the UK-b... | cambridgen... |
| 12.01.2022 | NeoCura and PhoreMost announce research collaboration to exp... | NeoCura and PhoreMost announce research collaboration to explore novel cancer therapeutics
12-01-20... | cambridgen... |
| 11.01.2022 | NeoCura and PhoreMost announce research collaboration to exp... | NeoCura and PhoreMost announce research collaboration to explore novel cancer therapeutics
11-01-20... | cambridgen... |
| 15.06.2021 | PhoreMost appoints Christian Dillon as Vice President of Bio... | PhoreMost appoints Christian Dillon as Vice President of Biology
15-06-2021
PhoreMost Ltd, the UK-... | cambridgen... |
| 25.03.2021 | PhoreMost’s £33m investment success for disease targets | PhoreMost has completed a £33m Series B investment round. | cambridgea... |
| 24.03.2021 | This Cambridge AI drug startup raises £33M to tackle ‘undrug... | The Cambridge, UK-based AI drug startup – PhoreMost has recently secured £33m funding in oversubscri... | uktech.new... |
| 23.03.2021 | PhoreMost Raises $46M in Series B Financing | PhoreMost Ltd., a Cambridge, England, UK-based biopharmaceutical company, raised $46m in Series B fu... | finsmes.co... |
| 23.03.2021 | PhoreMost Closes £33M ($46M) Series B Financing | PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ dise... | marketscre... |
| 23.03.2021 | PhoreMost closes £33M Series B financing | PhoreMost closes £33M Series B financing
23-03-2021
PhoreMost Ltd, the UK-based biopharmaceutical ... | cambridgen... |
| 23.03.2021 | PhoreMost closes £33M Series B financing | PhoreMost Ltd, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disea... | cambridgen... |
| 15.03.2021 | NeoPhore announces £15.2m financing to advance DNA mismatch ... | NeoPhore Limited, a small molecule neoantigen immuno-oncology company, has announced the close of a ... | cambridgen... |
| 15.03.2021 | NeoPhore announces £15.2m financing to advance DNA mismatch ... | NeoPhore announces £15.2m financing to advance DNA mismatch repair pipeline
15-03-2021
NeoPhore Li... | cambridgen... |
| 09.11.2020 | PhoreMost and Oxford Biomedica enter gene therapy discovery ... | PhoreMost and Oxford Biomedica enter gene therapy discovery collaboration
09-11-2020
PhoreMost Lim... | cambridgen... |
| 12.03.2020 | Cofinitive shortlisted in 30th Anniversary Business Weekly A... | Cofinitive shortlisted in 30th Anniversary Business Weekly Awards
12-03-2020
Cofinitive are deligh... | cambridgen... |
| 22.01.2020 | PhoreMost enters multi-project drug discovery collaboration ... | PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical
22-01-2020
... | cambridgen... |
| 27.02.2019 | Cofinitive shortlisted for International Trade Champion awar... | Cofinitive shortlisted for International Trade Champion award at Business Weekly Awards
27-02-2019
... | cambridgen... |
| 15.05.2018 | PhoreMost Completes $15M in Series Funding | PhoreMost, a Cambridge, England, UK-based biopharmaceutical company, completed a $15m (£11m) Series ... | finsmes.co... |
| 15.05.2018 | PhoreMost completes £11M ($15M) Series-A round to enter drug... | PhoreMost completes £11M ($15M) Series-A round to enter drug discovery
15-05-2018
PhoreMost, the U... | cambridgen... |
| 30.04.2018 | Cancer immunotherapy research receives £1m Innovate UK fundi... | Cancer immunotherapy research receives £1m Innovate UK funding
30-04-2018
PhoreMost Limited and Ne... | cambridgen... |
| 16.11.2017 | NeoPhore Raises £3M in Funding | NeoPhore Ltd, a spin out from Cambridge, UK – based PhoreMost Ltd., focused on the discovery and dev... | finsmes.co... |
| 12.10.2016 | PhoreMost Ltd and University of Cambridge collaborate to ide... | PhoreMost Ltd and University of Cambridge collaborate to identify innovative drug targets
12-10-201... | cambridgen... |
| 10.03.2016 | PhoreMost and The Wistar Institute collaborate to identify n... | PhoreMost and The Wistar Institute collaborate to identify new druggable targets
10-03-2016
PhoreM... | cambridgen... |
| 07.04.2015 | PhoreMost Raises £4M in Funding | PhoreMost, a Cambridge, UK-based biopharmaceutical company, raised £4m in Series A equity and grant ... | finsmes.co... |
| 07.04.2015 | Cambridge biopharma start-up attracts £4m to develop next-ge... | Cambridge biopharma start-up attracts £4m to develop next-gen screening platform
07-04-2015
PhoreM... | cambridgen... |
| 07.04.2015 | PhoreMost raises £2.5m to identify new druggable targets for... | PhoreMost Ltd, a biopharmaceutical company and University of Cambridge spin-out founded to identify ... | cambridgen... |
| 07.04.2015 | PhoreMost raises £2.5m to identify new druggable targets for... | PhoreMost raises £2.5m to identify new druggable targets for therapeutics
07-04-2015
PhoreMost Ltd... | cambridgen... |
| 07.04.2015 | PhoreMost Ltd founded to identify new druggable targets for ... | PhoreMost Ltd founded to identify new druggable targets for therapeutics
07-04-2015
PhoreMost Ltd,... | cambridgen... |
| - | PhoreMost – completes an oversubscribed $46m Series B invest... | Parkwalk are pleased to announce an investment in PhoreMost, as part of a £33m ($46m) Series B fundi... | parkwalkad... |
| - | This Cambridge AI drug startup raises £33M to tackle ‘undrug... | The Cambridge, UK-based AI drug startup – PhoreMost has recently secured £33m funding in oversubscri... | uktech.new... |
| - | Investment: Enhanc3D Genomics raises £10m in Series A fundin... | Parkwalk is delighted to announce an investment into Enhanc3D Genomics as part of a £10m Series A fu... | parkwalkad... |
| - | Parkwalk – The UK’s leading university spinout investor, CEO... | As the UK’s leading investor in university spinouts, Parkwalk’s CEO, Moray Wright, discusses the ori... | parkwalkad... |
| - | Parkwalk closes PhoreMost investment | We are pleased to announce that the University of Cambridge Enterprise Fund III has made an investme... | parkwalkad... |
| - | EIS: more than financial returns | As institutional investors increasingly regard ESG as an important element of their investment decis... | parkwalkad... |
| - | BGF leads £33m investment round into biopharmaceutical compa... | BGF has led an oversubscribed £33m investment round into PhoreMost Ltd., the UK-based biopharmaceuti... | bgf.co.uk/... |
